On Tuesday, July 19, the NIH announced two grant programs for newborn screening research. The Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Diabetes and Digestive Kidney Disease, and National Institute on Deafness and Other Communication Disorders jointly issued a funding opportunity announcement (FOA) for an R21 program. A grant through the program will support research regarding therapeutic solutions for currently screened conditions and “high-priority” genetic diseases, which may be part of newborn screening in the near future. The grants will provide up to $275,000 for research projects, which can span a maximum of two years. For more information about this grant opportunity, go to: http://grants.nih.gov/grants/guide/pa-files/PAR-10-232.html

The NIH also issued an FOA for an R03 program, which will also fund research relevant to therapeutic solutions for currently screened and “high-priority” conditions. The grant program can provide funds for different types of research, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 program provides grants for institutions with limited resources to carry out smaller projects over a shorter period of time. Both grants will also support research about genetic risk factors and the relationship between phenotype and genotype. For more information about this funding opportunity, go to: http://grants.nih.gov/grants/guide/pa-files/PAR-10-231.html

Trackback URI | Comments RSS